PharmaBoardroom

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the…

Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how…

The Mexico country manager of the Swiss biopharmaceutical company discusses the recent restructuring process the subsidiary has been going through,…

“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a…

Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of…

The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you…

The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in…